Fortrea to Acquire the Early Phase Services business from Worldwide in an all-cash transaction valued at approximately $45M.
Fortrea enters into a definitive agreement to acquire the Early Phase Services division of Worldwide Clinical TrialsIncludes a 60,000 sq. ft. GLP bioanalytical lab in Austin; a 200-bed GCP-compliant clinical
Fortrea is buying a business that helps test new medicines from another company for $45 million. This shows Fortrea is growing and getting better tools to do its job, which is worth watching to see if it helps the company earn more money.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.